Vascular pro-oxidant effects related to the autoxidation of dopamine

References

• Graham DG, Tiffany SM, Bell WR, Jr, Gutknecht WF. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 1978; 14: 644–653
   PubMed Web of Science ®Google Scholar
• Herlinger E, Jameson RF, Linert W. Spontaneous autoxidation of dopamine. J Chem Soc [Perkin II] 1995; 2: 259–263
   Google Scholar
• Graumann R, Paris I, Martínez P, Rumanque P, Marín P, Díaz-Grez F, Caviedes R, Caviedes P, Segura-Aguilar J. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT–diaphorase. Pol J Pharmacol 2002; 54: 573–579
   Google Scholar
• Ikemoto K, Nagatsu I, Ito S, King RA, Nishimura A, Nagatsu T. Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?. Neurosci Lett 1998; 253: 198–200
   Google Scholar
• Zecca L, Tampellini D, Gerlach M, Riederer M, Fariello RG, Sulzer D. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. J Clin Pathol Mol Pathol 2001; 54: 414–418
   Web of Science ®Google Scholar
• Bisaglia M, Mammi S, Bubacco L. Kinetic and structural analysis of the early oxidation products of dopamine. Analysis of the interactions with α-synuclein. J Biol Chem 2007; 282: 15597–15605
   PubMedGoogle Scholar
• Costa C, Bertazzo A, Allegri G, Toffano G, Curcuruto O, Traldi P. Melanin biosynthesis from dopamine. II. A mass spectrometric and collisional spectroscopic investigation. Pigment Cell Res 1992; 5: 122–131
   Google Scholar
• Asanuma M, Miyazaki I, Diaz-Corrales FJ, Ogawa N. Quinone formation as dopaminergic neuron-specific oxidative stress in pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism. Acta Med Okayama 2004; 58: 221–233
   PubMed Web of Science ®Google Scholar
• Hermida-Ameijeiras A, Méndez-Álvarez E, Sánchez-Iglesias S, Sanmartín-Suárez C, Soto-Otero R. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem Inter 2004; 45: 103–116
   PubMed Web of Science ®Google Scholar
• Stokes AH, Hastings TG, Vrana KE. Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 1999; 55: 659–665
   PubMed Web of Science ®Google Scholar
• Pattison DI, Dean RT, Davies MJ. Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. Toxicology 2002; 177: 23–37
   PubMed Web of Science ®Google Scholar
• Chen L, Ding Y, Cagniard B, Van Laar AD, Mortimer A, Chi A, Hastings TG, Kang UJ, Zhuang X. Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 2008; 28: 425–433
   PubMed Web of Science ®Google Scholar
• Ito S, Kato T, Fujita K. Covalent binding of catechols to proteins through the sulphydryl group. Biochem Pharmacol 1988; 37: 1707–1710
   PubMed Web of Science ®Google Scholar
• Haque ME, Asanuma M, Higashi Y, Miyazaki I, Tanaka K, Ogawa N. Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta 2003; 1619: 39–52
   PubMed Web of Science ®Google Scholar
• Pedrosa R, Soares-Da-Silva P. Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine. Br J Pharmacol 2002; 137: 1305–1313
   PubMed Web of Science ®Google Scholar
• Siraki AG, Smythies J, O'Brien PJ. Superoxide radical scavenging and attenuation of hypoxia-reoxygenation injury by neurotransmitter ferric complexes in isolated rat hepatocytes. Neurosci Lett 2000; 296: 37–40
   Google Scholar
• Buhmann C, Arlt S, Kontush A, Moller-Bertram T, Sperber S, Oechsner M, Stuerenburg HJ, Beisiegel U. Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication. Neurobiol Dis 2004; 15: 160–170
   PubMed Web of Science ®Google Scholar
• Angus JA, Cocks TM, Satoh K. α2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol 1986; 88: 767–777
   PubMed Web of Science ®Google Scholar
• Graham DG. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol 1978; 14: 633–643
   PubMed Web of Science ®Google Scholar
• Meredith P, Powell BJ, Riesz J, Nighswander-Rempel SP, Pederson MR, Moore EG. Towards structure–property–function relationships for eumelanin. Soft Matter 2006; 2: 37–44
   PubMed Web of Science ®Google Scholar
• Dagnino-Subiabre A, Cassels BK, Baez S, Johansson A-S, Mannervik B, Segura-Aguilar J. Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. Biochem Biophys Res Commun 2000; 274: 32–36
   PubMed Web of Science ®Google Scholar
• Gil-Longo J, González-Vázquez C. Characterization of four different effects elicited by H2O2 in rat aorta. Vascul Pharmacol 2005; 43: 128–138
   PubMed Web of Science ®Google Scholar
• Varma DR, Chemtob S. Endothelium- and beta-2 adrenoceptor-independent relaxation of rat aorta by tyramine and certain other phenylethylamines. J Pharmacol Exp Ther 1993; 265: 1096–1104
   Google Scholar
• Gao YJ, Hirota S, Zhang DW, Janssen LJ, Lee RMKW. Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. Br J Pharmacol 2003; 138: 1085–1092
   PubMed Web of Science ®Google Scholar
• Hayer-Zillgen M, Brüss M, Bönisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 2002; 136: 829–836
   PubMed Web of Science ®Google Scholar
• Li J, Li W, Su J, Liu W, Altura BT, Altura BM. Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: possible relation to neurodegenerative diseases and strokes. Brain Res Bull 2003; 62: 101–106
   PubMed Web of Science ®Google Scholar
• LeBlanc J, Ducharme MB. Plasma dopamine and noradrenaline variations in response to stress. Physiol Behav 2007; 91: 208–211
   PubMed Web of Science ®Google Scholar
• Garris PA, Ciolkowski EL, Pastore P, Wightman RM. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 1994; 14: 6084–6093
   PubMed Web of Science ®Google Scholar
• Mac Gregor DA, Smith TE, Prielipp RC, Butterworth JF, James RL, Scuderi PE. Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology 2000; 92: 338–346
   Google Scholar
• Dethy S, Laute MA, Van Blercom N, Damhaut P, Goldman S, Hildebrand J. Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients. Clin Chem 1997; 43: 740–744
   PubMed Web of Science ®Google Scholar
• Bouhaddi M, Vuillier F, Fortrat JO, Cappelle S, Henriet MT, Rumbach L, Regnard J. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy. Auton Neurosci Basic Clin 2004; 116: 30–38
   PubMed Web of Science ®Google Scholar